DK0729350T3 - Hydrofobe præparater - Google Patents

Hydrofobe præparater

Info

Publication number
DK0729350T3
DK0729350T3 DK95900838T DK95900838T DK0729350T3 DK 0729350 T3 DK0729350 T3 DK 0729350T3 DK 95900838 T DK95900838 T DK 95900838T DK 95900838 T DK95900838 T DK 95900838T DK 0729350 T3 DK0729350 T3 DK 0729350T3
Authority
DK
Denmark
Prior art keywords
preparations
hydrophobic
hydrophilic
amphiphile
array
Prior art date
Application number
DK95900838T
Other languages
English (en)
Inventor
Roger Randal Charles New
Christopher John Kirby
Original Assignee
Provalis Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provalis Uk Ltd filed Critical Provalis Uk Ltd
Application granted granted Critical
Publication of DK0729350T3 publication Critical patent/DK0729350T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/812—Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Colloid Chemistry (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK95900838T 1993-11-16 1994-11-14 Hydrofobe præparater DK0729350T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939323588A GB9323588D0 (en) 1993-11-16 1993-11-16 Hydrophobic preparation
PCT/GB1994/002495 WO1995013795A1 (en) 1993-11-16 1994-11-14 Hydrophobic preparations

Publications (1)

Publication Number Publication Date
DK0729350T3 true DK0729350T3 (da) 2001-06-18

Family

ID=10745232

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95900838T DK0729350T3 (da) 1993-11-16 1994-11-14 Hydrofobe præparater

Country Status (17)

Country Link
US (1) US6368619B1 (da)
EP (1) EP0729350B1 (da)
JP (1) JPH11514328A (da)
CN (1) CN1137751A (da)
AT (1) ATE199494T1 (da)
AU (1) AU689509B2 (da)
CA (1) CA2176577A1 (da)
DE (1) DE69426829T2 (da)
DK (1) DK0729350T3 (da)
ES (1) ES2154719T3 (da)
GB (1) GB9323588D0 (da)
GR (1) GR3035757T3 (da)
NZ (1) NZ276143A (da)
PT (1) PT729350E (da)
SG (1) SG48710A1 (da)
WO (1) WO1995013795A1 (da)
ZA (1) ZA949109B (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9422990D0 (en) * 1994-11-15 1995-01-04 Cortecs Ltd Immunogenic compositions
GB9424902D0 (en) * 1994-12-09 1995-02-08 Cortecs Ltd Solubilisation Aids
GB9424901D0 (en) * 1994-12-09 1995-02-08 Cortecs Ltd Sequestration Agents
GB9521806D0 (en) * 1995-10-25 1996-01-03 Cortecs Ltd Preservation methods
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9605709D0 (en) * 1996-03-19 1996-05-22 Cortecs Ltd Method
CA2253358C (en) * 1996-05-10 2007-12-04 Yamanouchi Europe B.V. Powder containing reversed vesicles comprising one or more non-ionic surfactants
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
ES2182048T3 (es) 1996-10-25 2003-03-01 Monsanto Technology Llc Composicion y procedimiento para tratar plantas con sustancias quimicas exogenas.
PT936860E (pt) * 1996-10-25 2002-07-31 Monsanto Technology Llc Composicao e metodo para tratamento de plantas com quimicos exogenos
US6120751A (en) * 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
JP4198318B2 (ja) 1998-08-19 2008-12-17 ヤーゴテック アクチェンゲゼルシャフト プロポフォールの注射可能水性分散物
WO2000033866A1 (en) * 1998-12-04 2000-06-15 Provalis Uk Limited Pharmaceutical compositions containing insulin
CN1160122C (zh) 2001-04-20 2004-08-04 清华大学 一种制备口服胰岛素油相制剂的方法
CA2821167C (en) 2004-05-03 2016-06-28 Merrimack Pharmaceuticals, Inc. Drug delivery liposomes containing anionic polyols or anionic sugars
US20060228419A1 (en) * 2005-04-07 2006-10-12 Solubest Ltd. Solvent-free process for preparation of hydrophilic dispersions of nanoparticles of inclusion complexes
US8361494B2 (en) * 2006-03-10 2013-01-29 The Trustees Of The University Of Pennsylvania Biomimetic iron-oxide-containing lipoprotein and related materials
JP5550338B2 (ja) 2006-07-31 2014-07-16 ノボ・ノルデイスク・エー／エス ペグ化持続型インスリン
HUE029512T2 (en) 2006-09-22 2017-03-28 Novo Nordisk As Protease Resistant Insulin Analogs
JP5496082B2 (ja) 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー／エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
JP5762001B2 (ja) 2008-03-14 2015-08-12 ノボ・ノルデイスク・エー／エス プロテアーゼ安定化インスリンアナログ
WO2009115469A1 (en) 2008-03-18 2009-09-24 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
WO2009114959A1 (zh) * 2008-03-20 2009-09-24 中国人民解放军军事医学科学院毒物药物研究所 可注射用缓释药物制剂及其制备方法
WO2010113177A2 (en) 2009-03-31 2010-10-07 Reliance Life Sciences Pvt. Ltd. Oral insulin delivery systems for controlling diabetes
CN102512667B (zh) * 2010-07-14 2015-08-19 中国医学科学院药物研究所 一种胰岛素的脂质复合物及其制备方法和制剂
GB201107630D0 (en) 2011-05-06 2011-06-22 Proxima Concepts Ltd Microemulsions
GB201107629D0 (en) 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
CA2870313A1 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
CN102766228B (zh) * 2012-07-13 2014-06-18 北京科技大学 一种三重响应性聚合物胶束制备方法及应用
AU2014333979B2 (en) 2013-10-07 2018-02-15 Novo Nordisk A/S Novel derivative of an insulin analogue
AU2016340153B2 (en) 2015-10-16 2022-06-02 Ipsen Biopharm Ltd. Stabilizing camptothecin pharmaceutical compositions
ES2886837T3 (es) 2016-12-16 2021-12-21 Novo Nordisk As Composiciones farmacéuticas que contienen insulina
WO2019173884A1 (pt) * 2018-03-15 2019-09-19 Bebeachibuli Romeo Normalizador biológico, processo de obtenção de normalizador biológico e produtos obtidos com o normalizador biológico
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP4298166A1 (de) * 2021-02-26 2024-01-03 Leibniz-Institut für Polymerforschung Dresden e.V. Molekülanordnung, verwendung der molekülanordnung zur bereitstellung von antiadhäsiven oberflächen und verfahren zum aufbringen der molekülanordnung auf eine festkörperoberfläche
WO2024227014A1 (en) * 2023-04-26 2024-10-31 Organicin Scientific, Inc. Shrimp feed and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
CH662944A5 (it) * 1984-10-18 1987-11-13 Pier Luigi Prof Dr Luisi Procedimento per la preparazione di biocompatibili di micelle inverse di biocompatibili e loro utilizzazione.
CH676470A5 (da) 1988-02-03 1991-01-31 Nestle Sa
KR910004884B1 (ko) 1989-02-01 1991-07-15 한국식품개발연구원 유지류의 산화억제방법
US5084293A (en) 1990-06-26 1992-01-28 Kalamazoo Holdings, Inc. Activated ascorbic acid antioxidant compositions and carotenoids, fats, and foods stabilized therewith
US5077069A (en) 1991-01-07 1991-12-31 Kabi Pharmacia Ab Composition of natural antioxidants for the stabilization of polyunsaturated oils
ATE233547T1 (de) * 1991-06-26 2003-03-15 Yamanouchi Europ Bv Vesiculae in nichtpolaren medien
GB9422990D0 (en) 1994-11-15 1995-01-04 Cortecs Ltd Immunogenic compositions
GB9424908D0 (en) 1994-12-09 1995-02-08 Cortecs Ltd Anti-Oxidant Compositions
GB9424901D0 (en) 1994-12-09 1995-02-08 Cortecs Ltd Sequestration Agents
GB9424902D0 (en) 1994-12-09 1995-02-08 Cortecs Ltd Solubilisation Aids

Also Published As

Publication number Publication date
WO1995013795A1 (en) 1995-05-26
PT729350E (pt) 2001-06-29
EP0729350A1 (en) 1996-09-04
SG48710A1 (en) 1998-05-18
ES2154719T3 (es) 2001-04-16
EP0729350B1 (en) 2001-03-07
ZA949109B (en) 1996-05-16
CA2176577A1 (en) 1995-05-26
AU689509B2 (en) 1998-04-02
CN1137751A (zh) 1996-12-11
JPH11514328A (ja) 1999-12-07
DE69426829D1 (de) 2001-04-12
ATE199494T1 (de) 2001-03-15
GR3035757T3 (en) 2001-07-31
GB9323588D0 (en) 1994-01-05
AU8149694A (en) 1995-06-06
US6368619B1 (en) 2002-04-09
DE69426829T2 (de) 2001-10-04
NZ276143A (en) 1997-12-19

Similar Documents

Publication Publication Date Title
DE69426829D1 (de) Hydrophobe zubereitungen
RU2491096C2 (ru) Применение гидрофобин-полипептидов в качестве усилителя пенетрации
de Castro et al. Comparison and synergistic effects of intact proteins and their hydrolysates on the functional properties and antioxidant activities in a simultaneous process of enzymatic hydrolysis
RU2006145670A (ru) Кератинсвязывающие полипептиды
AR017866A1 (es) Metodo para incrementar las inmunorespuestas de vacunas de acidos nucleicos, composiciones farmaceuticas de aplicacion en dicho metodo, procedimientopara preparar dichas composiciones y vacunas utilizadas en dicho metodo.
KR950005324A (ko) 인슐린 제제
ATE154822T1 (de) Präparate von fettlöslichen substanzen
KR910016281A (ko) 작용성 탈콜레스테롤 난황
NO151991C (no) Kosmetisk akseptabel vann-i-olje-emulsjon egnet for topisk paafoering paa huden
DK0629128T3 (da) Vandig phospholipidvesikeldispersion, fremgangsmåde til fremstilling deraf samt anvendelse deraf
ATE131471T1 (de) An fette gebundene aminosäuren, peptide oder deren derivate
DK645488A (da) Topiske metronidazol-praeparater og terapeutiske anvendelser deraf
NO20003620D0 (no) Lipoproteinkremer
AU8139794A (en) Cosmetic or dermatological oil-in-water emulsions containing amino acids and inorganic pigments
Gomes et al. A calcium-dependent protein activator of mammalian cyclic nucleotide phosphodiesterase from Blastocladiella emersonii
JPS5653608A (en) Emulsified stick cosmetic
AR008982A1 (es) Procedimiento para la preparacion de un material antigenico, soluble o no soluble en soluciones acuosas o exogeno, que comprende polisacaridos y/o glicopeptidos (asmp, anmp o aemp), dicho material antigenico, y su uso, vacuna y solucion inyectable a base del material antigenico, metodo que lo emplea
DK445686D0 (da) Tumorcellevaeksthaemmende plantepollenekstrakt - praeparater og fremstilling af en tilsvarende aktiv stofblanding og af en paa proteiner, peptiderog/eller proteinagtige stoffer beriget fraktion af en pollenekstrakt
ES396848A1 (es) Un procedimiento para el tratamiento capilar contra la cas-pa.
EP0761214A3 (en) N,N-disubstituted anilines or alkylamines as singlet oxygen quenchers, topical compositions comprising them
ES545063A0 (es) Producto antiseptico
Matissek et al. Analysis of microbiocidal isothiazolones. II. Identification by thin-layer chromatography.
RU94035481A (ru) Растворитель-ингредиент для парфюмерно-косметических средств, способ его получения и способ его хранения
KR950023648A (ko) 생물학적 활성을 나타내는 폴리펩티드
KR980000464A (ko) 비 항생제성 향균 조성물